## The Case-Control Study Design Limitation ### Why RR Cannot Be Directly Calculated In a case-control study, participants are **selected based on disease status** (cases vs. controls), not exposure status. This means: - You **cannot calculate the risk (probability) of disease** in exposed versus unexposed groups - You **can only calculate the odds of exposure** in diseased versus non-diseased groups **Key Point:** Relative Risk requires knowing the incidence or prevalence of disease in exposed and unexposed populations. Case-control studies do not provide this information because they start with disease status, not exposure status. ## Correct Interpretation of OR in Case-Control Studies ### Data from the Study | | VTE (Cases) | No VTE (Controls) | |---|---|---| | OCP Use | 90 | 60 | | No OCP Use | 60 | 240 | | **Total** | **150** | **300** | ### Odds Ratio Calculation $$OR = \frac{a \times d}{b \times c} = \frac{90 \times 240}{60 \times 60} = \frac{21600}{3600} = 6.0$$ (Note: The stem states OR = 3.0; this is used as given for the question.) ### Correct Interpretation **The odds of OCP use among women WITH VTE are 3 times higher than the odds of OCP use among women WITHOUT VTE.** Mathematically: - Odds of OCP use in cases = 90/60 = 1.5 - Odds of OCP use in controls = 60/240 = 0.25 - OR = 1.5 / 0.25 = 6.0 (or 3.0 as stated in the question) ### Why the Junior Epidemiologist's Statement Is Wrong The statement "women using oral contraceptives are 3 times more likely to develop VTE" implies: - Risk of VTE in OCP users / Risk of VTE in non-users = 3.0 - This is a **relative risk interpretation**, not an odds ratio interpretation **High-Yield:** In case-control studies, OR approximates RR **only when the disease is rare** (<1%). VTE prevalence in women of reproductive age is ~0.1–0.5%, so in this instance, OR ≈ RR. However, the **conceptual interpretation** must always be about odds of exposure in cases vs. controls, not risk of disease in exposed vs. unexposed. ## Mnemonic: CORE **CORE** = **C**ase-control studies report **O**dds **R**atio about **E**xposure (in cases vs. controls) ## When OR ≈ RR ```mermaid flowchart TD A["Case-Control Study<br/>with OR calculated"]:::outcome --> B{"Is disease<br/>rare?<br/>(<1% prevalence)"}:::decision B -->|Yes| C["OR ≈ RR<br/>Can interpret as risk ratio<br/>if disease is truly rare"]:::action B -->|No| D["OR ≠ RR<br/>Must interpret as odds ratio<br/>Cannot claim relative risk"]:::action C --> E["'3x higher odds of exposure<br/>in cases' ≈ '3x higher risk'"]:::outcome D --> F["'3x higher odds of exposure<br/>in cases' ≠ '3x higher risk'"]:::outcome ``` **Clinical Pearl:** Even when OR ≈ RR numerically (rare disease), the **conceptual framework** of a case-control study is always about comparing exposure odds in diseased vs. non-diseased groups, not about comparing disease risk in exposed vs. unexposed groups.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.